Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
Biorxiv : the Preprint Server for Biology|July 9, 2024
A widespread electrical brain network encodes anxiety in health and depressive statesDalton N Hughes, Michael Hunter Klein, Kathryn Katsue Walder-Christensen, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
JCI Insight|March 7, 2023
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent mannerMichael Brandon Ware, Maggie Phillips, Christopher McQuinn, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Cancers|September 9, 2023
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer SurvivorshipAnnelise A Madison, Rebecca Andridge, Anthony H Kantaras, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Biomaterials Science|August 30, 2023
ICAM-1-decorated extracellular vesicles loaded with miR-146a and <i>Glut1</i> drive immunomodulation and hinder tumor progression in a murine model of breast cancerSilvia Duarte-Sanmiguel, Ana I Salazar-Puerta, Ana Panic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
Biorxiv : the Preprint Server for Biology|July 9, 2024
A widespread electrical brain network encodes anxiety in health and depressive statesDalton N Hughes, Michael Hunter Klein, Kathryn Katsue Walder-Christensen, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
JCI Insight|March 7, 2023
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent mannerMichael Brandon Ware, Maggie Phillips, Christopher McQuinn, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Cancers|September 9, 2023
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer SurvivorshipAnnelise A Madison, Rebecca Andridge, Anthony H Kantaras, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Biomaterials Science|August 30, 2023
ICAM-1-decorated extracellular vesicles loaded with miR-146a and <i>Glut1</i> drive immunomodulation and hinder tumor progression in a murine model of breast cancerSilvia Duarte-Sanmiguel, Ana I Salazar-Puerta, Ana Panic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Pageof 28